|
1
|
Li S, Zhao K, Liu S, Wu C, Yao Y, Cao L,
Hu X, Zhou Y, Wang Y, Pei R, et al: HBsAg sT123N mutation induces
stronger antibody responses to HBsAg and HBcAg and accelerates in
vivo HBsAg clearance. Virus Res. 210:119–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Ge J, Ren S, Zhou T, Sun Y, Sun H,
Gu Y, Huang H, Xu Z, Chen X, et al: Hepatitis B surface antigen
(HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides
as a novel therapeutic vaccine for chronic hepatitis B infection.
Vaccine. 33:4247–4254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia H, Li C, Zhang Y, Yu L, Xiang D, Liu
J, Chen F and Han X: Immunostimulatory activities of dendritic
cells loaded with adenovirus vector carrying HBcAg/HBsAg. Int J
Clin Exp Med. 8:3456–3464. 2015.PubMed/NCBI
|
|
4
|
Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin
HH, Hwang LH, Chen PJ and Chen DS: Cellular immune response to
HBcAg in mother-to-infant transmission of hepatitis B virus.
Hepatology. 15:770–776. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karpenko LI, Veremeiko TA, Ignat'ev GM,
Poryvaeva VA, Baĭborodin SI, Boĭchenko MN, Il'ichev AA and Vorob'ev
AA: Comparative study of the effectiveness of HBcAg presentation to
the immune system using attenuated Salmonella strains, serovars
S.enteritidis and S.typhimurium. Zh Mikrobiol
Epidemiol Immunobiol. 34–38. 2001.(In Russian). PubMed/NCBI
|
|
6
|
Liu ZH, Feng GF, Li YY, Ma YB and Hu HT:
Biological effects of immune serum from fusion protein of
beta-amyloid peptide and HbcAg/MIR on AD transgeneic cells. Sichuan
Da Xue Xue Bao Yi Xue Ban. 38:608–612. 2007.(In Chinese).
PubMed/NCBI
|
|
7
|
zum Büschenfelde Meyer KH, Arnold W,
Knolle J and Hess G: Immune response to HBsAg, HBcAg and e-antigen
in patients with acute hepatitis and HBsAg carriers with and
without liver diseases. Z Gastroenterol. 14:365–377. 1976.(In
German). PubMed/NCBI
|
|
8
|
Chen XC, Zhou BP, Li MZ, Wang ZX, Wang HS,
Zhang B and Tang W: Immune response in mice induced by the fusion
protein of HBcAg and HBV PreS1. Zhonghua Gan Zang Bing Za Zhi.
11:184–185. 2003.(In Chinese). PubMed/NCBI
|
|
9
|
Feng IC, Koay LB, Sheu MJ, Kuo HT, Sun CS,
Lee C, Chuang WL, Liao SK, Wang SL, Tang LY, et al: HBcAg-specific
CD4+CD25+ regulatory T cells modulate immune tolerance and acute
exacerbation on the natural history of chronic hepatitis B virus
infection. J Biomed Sci. 14:43–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyakawa Y: Determination of HBcAg and
anti-HBc by immune adherence hemagglutination and association of
HBcAg with e antigen. Bibl Haematol. 42:70–71. 1976.PubMed/NCBI
|
|
11
|
Szkaradkiewicz A, Jopek A and Wysocki J:
Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by
CD4 T lymphocytes of children with chronic hepatitis B infection.
Antiviral Res. 66:23–27. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szkaradkiewicz A, Jopek A, Wysocki J,
Grzymislawski M, Malecka I and Wozniak A: HBcAg-specific cytokine
production by CD4 T lymphocytes of children with acute and chronic
hepatitis B. Virus Res. 97:127–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cooper A, Tal G, Lider O and Shaul Y:
Cytokine induction by the hepatitis B virus capsid in macrophages
is facilitated by membrane heparan sulfate and involves TLR2. J
Immunol. 175:3165–3176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Zhou ZH, Sun XH, Zhang X, Zhu XJ,
Jin SG, Gao YT, Jiang Y and Gao YQ: Hepatitis B core antigen
upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38
pathway: A possible mechanism of hepatitis B virus persistence. Lab
Invest. 96:1156–1164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Q, Liu C, Zhu F, Liu F, Zhang P, Guo
C, Wang X, Li H, Ma C, Sun W, et al: Reoxygenation of
hypoxia-differentiated dentritic cells induces Th1 and Th17 cell
differentiation. Mol Immunol. 47:922–931. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding YS and Chen WM: Anti-myloma activity
of T cell activated by dentritic cells loading antigen of U266
cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 15:581–585. 2007.(In
Chinese). PubMed/NCBI
|
|
17
|
Ko H, Hambly BD, Eris JM, Levidiotis V,
Wyburn K, Wu H, Chadban SJ and Yin JL: Dentritic cell derived IL-18
production is inhibited by rapamycin and sanglifehrin A, but not
cyclosporine A. Transpl Immunol. 20:99–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang H, Zhang Y, Wu M, Li J, Zhou W, Li G,
Li X, Xiao B and Christadoss P: Suppression of ongoing experimental
autoimmune myasthenia gravis by transfer of RelB-silenced bone
marrow dentritic cells is associated with a change from a T helper
Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Inflamm
Res. 59:197–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu TH: Recent advance and classification
of histocytic and dentritic cell neoplasms. Zhonghua Bing Li Xue Za
Zhi. 34:373–374. 2005.(In Chinese). PubMed/NCBI
|
|
20
|
Zhou JY, Zhou DF and Li JQ: PD-1
expression in HBcAg-specific CD8+ T cells of adolescents with
chronic HBV infection. Zhonghua Gan Zang Bing Za Zhi. 21:27–32.
2013.(In Chinese). PubMed/NCBI
|
|
21
|
Wang S, Han Q, Zhang G, Zhang N, Li Z,
Chen J, Lv Y, Li N, Xing F, Tian N, et al: CpG
oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg
epitope and HIV-Tat may elicit favorable immune response in PBMCs
from patients with chronic HBV infection in the immunotolerant
phase. Int Immunopharmacol. 11:406–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng B, Ganapathy S, Shen L, Huang J, Yi
B, Zhou X, Dai W and Chen C: Targeting Bcl-2 stability to sensitize
cells harboring oncogenic ras. Oncotarget. 6:22328–22337. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qian G, Hao S, Yang D and Meng Q: P15,
MDM2, NF-kB, and Bcl-2 expression in primary bone tumor and
correlation with tumor formation and metastasis. Int J Clin Exp
Pathol. 8:14885–14892. 2015.PubMed/NCBI
|
|
24
|
Qu Y, Qu B, Wang X, Wu R and Zhang X:
Knockdown of NF-kB p65 subunit expression suppresses proliferation
of nude mouse lung tumour cell xenografts by inhibition of Bcl-2
apoptotic pathway. Cell Biochem Funct. 33:320–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK,
Park WS and do Min S: Phorbol ester up-regulates phospholipase D1
but not phospholipase D2 expression through a
PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix
metalloproteinase-9 secretion in colon cancer cells. J Biol Chem.
283:4094–4104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sheng WY, Chen YR and Wang TC: A major
role of PKC theta and NFkappaB in the regulation of hTERT in human
T lymphocytes. FEBS Lett. 580:6819–6824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka A, Uegaki S, Kurihara H, Aida K,
Mikami M, Nagashima I, Shiga J and Takikawa H: Hepatic steatosis as
a possible risk factor for the development of hepatocellular
carcinoma after eradication of hepatitis C virus with antiviral
therapy in patients with chronic hepatitis C. World J
Gastroenterol. 13:5180–5187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohata K, Hamasaki K, Toriyama K, Matsumoto
K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, et
al: Hepatic steatosis is a risk factor for hepatocellular carcinoma
in patients with chronic hepatitis C virus infection. Cancer.
97:3036–3043. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dou XG: Immune tolerant phase of chronic
HBV infection-breaking or not. Zhonghua Gan Zang Bing Za Zhi.
20:730–732. 2012.(In Chinese). PubMed/NCBI
|
|
30
|
Ren YY, Liu YZ, Ding YP, Song G, Li SH and
Wang GQ: Immune characteristics of different immune phases in
natural course of chronic HBV infection. Hepatogastroenterology.
60:789–795. 2013.PubMed/NCBI
|
|
31
|
Zhao W, Liu W, Luo C and Wan JM: The
expression of HBsAg and HBcAg in the liver tissues of the patients
with chronic hepatitis B before and after the treatment with
arabinosyladenine. Zhonghua Gan Zang Bing Za Zhi. 12:4522004.(In
Chinese). PubMed/NCBI
|
|
32
|
Wang GS, Wang MM, Xie QL, Ming L, Jiang
XN, Chen LW and Liu MH: Expression and clinical significance of
HBsAg and HBcAg in hepatocytes in chronic hepatitis B. Zhonghua Gan
Zang Bing Za Zhi. 12:287–289. 2004.(In Chinese). PubMed/NCBI
|
|
33
|
Ding CL, Yao K, Zhang TT, Xu JY, Xu L and
Peng GY: Expression of HBcAg in eukaryotic cells by retroviral
vector mediated gene transfer. Zhonghua Shi Yan He Lin Chuang Bing
Du Xue Za Zhi. 17:81–84. 2003.(In Chinese). PubMed/NCBI
|
|
34
|
Zhang X, Xing H, Feng X, Zhang H, Wang Y
and Yan H: Hepatitis B virus (HBV)-specific T-cell responses to
recombinant HBV core protein in patients with normal liver function
and co-infected with chronic HBV and human immunodeficiency virus 1
(HIV-1). Virol J. 10:2322013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rana D, Menachery J, Chawla Y, Duseja A,
Dhiman R and Arora S: HBV specific T-cell responses in hepatitis B.
Trop Gastroenterol. 32:273–278. 2011.PubMed/NCBI
|
|
36
|
Becker LE, de Oliveira Biazotto F, Conrad
H, Schaier M, Kihm LP, Gross-Weissmann ML, Waldherr R, Bierhaus A,
Nawroth PP, Zeier M and Morath C: Cellular infiltrates and NFκB
subunit c-Rel signaling in kidney allografts of patients with
clinical operational tolerance. Transplantation. 94:729–737. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baiguera C, Alghisi M, Pinna A, Bellucci
A, De Luca MA, Frau L, Morelli M, Ingrassia R, Benarese M, Porrini
V, et al: Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.
Brain. 135:2750–2765. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Siervi A, De Luca P, Moiola C, Gueron
G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D,
Kawasaki E, et al: Identification of new Rel/NFkappaB regulatory
networks by focused genome location analysis. Cell Cycle.
8:2093–2100. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Madge LA and May MJ: The NFκB paradox:
RelB induces and inhibits gene expression. Cell Cycle. 10:6–7.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tanaka Y, Ota K, Kameoka M, Itaya A and
Yoshihara K: Up-regulation of NFkappaB-responsive gene expression
by DeltaNp73alpha in p53 null cells. Exp Cell Res. 312:1254–1264.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Murley JS, Kataoka Y, Hallahan DE, Roberts
JC and Grdina DJ: Activation of NFkappaB and MnSOD gene expression
by free radical scavengers in human microvascular endothelial
cells. Free Radic Biol Med. 30:1426–1439. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Scholz-Pedretti K, Eberhardt W, Rupprecht
G, Beck KF, Spitzer S, Pfeilschifter J and Kaszkin M: Inhibition of
NFkappaB-mediated pro-inflammatory gene expression in rat mesangial
cells by the enolized 1,3-dioxane-4, 6-dione-5-carboxamide,
CGP-43182. Br J Pharmacol. 130:1183–1190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma ZY, Zhong ZG, Qiu MY, Zhong YH and
Zhang WX: TGF-β1 activates the canonical NF-κB signaling to promote
cell survival and proliferation in dystrophic muscle fibroblasts in
vitro. Biochem Biophys Res Commun. 471:576–581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huo YN, Chen W and Zheng XX: ROS, MAPK/ERK
and PKC play distinct roles in EGF-stimulated human corneal cell
proliferation and migration. Cell Mol Biol (Noisy-le-grand).
61:6–11. 2015.PubMed/NCBI
|
|
45
|
Al-Alem LF, McCord LA, Southard RC,
Kilgore MW and Curry TE Jr: Activation of the PKC pathway
stimulates ovarian cancer cell proliferation, migration and
expression of MMP7 and MMP10. Biol Reprod. 89:732013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao X, Chen T, Xing D, Wang F, Pei Y and
Wei X: Single cell analysis of PKC activation during proliferation
and apoptosis induced by laser irradiation. J Cell Physiol.
206:441–448. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cho HM, Choi SH, Hwang KC, Oh SY, Kim HG,
Yoon DH, Choi MA, Lim S, Song H, Jang Y and Kim TW: The
Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth
muscle cell proliferation induced by glycated LDL. Mol Cells.
19:60–66. 2005.PubMed/NCBI
|
|
48
|
Jacques-Silva MC, Bernardi A, Rodnight R
and Lenz G: ERK, PKC and PI3K/Akt pathways mediate extracellular
ATP and adenosine-induced proliferation of U138-MG human glioma
cell line. Oncology. 67:450–459. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ji Y, Wang Z, Li Z, Zhang A, Jin Y, Chen H
and Le X: Angiotensin II enhances proliferation and inflammation
through AT1/PKC/NF-κB signaling pathway in hepatocellular carcinoma
cells. Cell Physiol Biochem. 39:13–32. 2016.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Leonard B, McCann JL, Starrett GJ,
Kosyakovsky L, Luengas EM, Molan AM, Burns MB, McDougle RM, Parker
PJ, Brown WL and Harris RS: The PKC/NF-κB signaling pathway induces
APOBEC3B expression in multiple human cancers. Cancer Res.
75:4538–4547. 2015. View Article : Google Scholar : PubMed/NCBI
|
